Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $69.00, but opened at $60.2750. Basilea Pharmaceutica shares last traded at $60.2750, with a volume of 12 shares traded.
Basilea Pharmaceutica Price Performance
The business’s 50 day simple moving average is $67.79 and its 200 day simple moving average is $67.86. The company has a quick ratio of 4.68, a current ratio of 5.11 and a debt-to-equity ratio of 0.59.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Basel, specializing in the development and commercialization of innovative treatments for hospital‐treated diseases. The company’s research is focused primarily on anti‐infectives and oncology, with a portfolio that spans both marketed products and early‐ to late‐stage pipeline candidates. Basilea leverages medicinal chemistry expertise to address critical medical needs in fungal infections, bacterial infections and cancer.
Among its lead products is isavuconazole, a broad‐spectrum antifungal agent marketed under the trade name Cresemba.
Recommended Stories
- Five stocks we like better than Basilea Pharmaceutica
- Applied Digital Is Building a $36 Billion AI Real Estate Empire
- Why Oracle’s 10% Drop May Be Telling the Wrong Story
- Build On a Strong Earnings Season With These 3 ETFs
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
